Women In Perimenopause Report More Anxiety Than Other Menopausal Groups
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

A systematic review of 21 studies involving 24,523 women found higher odds of reported anxiety symptoms among perimenopausal and postmenopausal women than among premenopausal women. Perimenopause had the highest odds in comparisons between stages, but the observational evidence does not show that menopause causes anxiety or that anxiety rises within individual women over time.

A systematic review of 21 studies involving 24,523 women found that women in perimenopause had higher odds of reporting anxiety symptoms than premenopausal women, while postmenopausal women also had elevated odds. The findings, published in Scientific Reports, point to perimenopause as a stage when anxiety may merit clinical attention, but do not establish that menopause causes anxiety.

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

Fifteen of the 21 studies contributed data to the meta-analysis. In pooled comparisons, women in perimenopause had 59% higher odds of reporting anxiety symptoms than premenopausal women. The corresponding odds for postmenopausal women were 63% higher than for premenopausal women.

In a direct comparison between the two later stages, postmenopausal women had 21% lower odds of reporting anxiety symptoms than perimenopausal women. The researchers said the overall pattern placed the highest odds in perimenopause, but results varied substantially across studies. These are comparisons of odds between groups, not estimates of how many women experience anxiety or how an individual’s symptoms change over time.

The review brought together observational research from multiple countries. It included studies using standardized questionnaires, interviews or broader mental-health measures containing anxiety items, and accepted definitions of reproductive stage. One study rated as low quality was excluded from the pooled analysis. The researchers used a random-effects model, a method that accounts for variation among studies.

At a glance
reportWhen: Review published October 2026; evidence…
The developmentA systematic review and meta-analysis found that reported anxiety symptoms were associated with higher odds during perimenopause than before menopause, with variation across studies.

Why Perimenopause Deserves Attention

The findings add pooled evidence to a question that has been difficult to answer: whether anxiety reporting differs across the stages before, during and after menopause. They may help clinicians and health systems decide whether anxiety should be addressed more directly when discussing the menopause transition.

The review does not show that menopause causes anxiety, nor does it establish that a woman’s anxiety will increase during perimenopause and then decrease afterward. Still, the group-level association suggests that asking about anxiety during this stage could help identify people who may benefit from assessment and support. The results are relevant to guidance because public health and clinical resources do not describe anxiety in the same way: the World Health Organization recognizes it as a possible menopause-related symptom, while UK NICE guidance does not explicitly list anxiety as one.

Products Worth Considering

Levoit Core 600S-P Smart Air Purifier for Large Rooms up to 2933 ft²

Levoit Core 600S-P Smart Air Purifier for Large Rooms up to 2933 ft²

Oral-B iO Series 7 Rechargeable Electric Toothbrush, Black, with 2 Brush Heads and Charging Travel Case

Oral-B iO Series 7 Rechargeable Electric Toothbrush, Black, with 2 Brush Heads and Charging Travel Case

As an affiliate, we earn on qualifying purchases.

How the Review Compared Stages

Menopause is defined retrospectively after 12 consecutive months without menstrual periods, when no other cause explains the absence. Perimenopause is the preceding period, during which menstrual cycles can become irregular. The review assessed anxiety across premenopausal, perimenopausal and postmenopausal groups rather than treating menopause as a single point in time.

Researchers searched MEDLINE, PsycINFO, Embase and Web of Science from their beginnings through August 16, 2024. They included cross-sectional and longitudinal observational studies of women aged 18 or older, using standardized staging criteria or equivalent definitions. For longitudinal studies, only baseline observations were included in the pooled comparisons, so the meta-analysis did not track changes within the same participants over time.

The review addresses a gap in earlier evidence. A 2012 narrative review had reported generally low anxiety across menopausal stages, but it did not use consistent staging criteria or pool quantitative estimates. The newer analysis provides numerical comparisons, though differences among the included studies remain a limit on how precisely the findings can be applied.

“Perimenopausal and postmenopausal women had significantly higher odds of anxiety symptoms compared with their premenopausal counterparts, with the highest odds observed during perimenopause.”

— The review authors

What the Evidence Cannot Establish

The studies were observational, so their pooled associations cannot establish cause and effect. They also do not show that anxiety symptoms rose within individual women as they moved through menopause: the pooled comparisons used baseline data from longitudinal studies alongside cross-sectional data.

Results varied substantially between studies, and the review’s figures describe odds, not the proportion of women affected or the severity of symptoms. The supplied report does not provide a single pooled absolute rate of anxiety for each stage. Proposed explanations involving hormonal changes, stress responses, sleep disruption or other menopause-related experiences are possible pathways discussed by the authors, not mechanisms demonstrated by this analysis.

How Guidance May Respond

The review’s findings may inform future research and discussion of mental-health support during the menopause transition. The authors say a clearer understanding of anxiety across defined stages could help shape clinical guidance and mental-health policy. No specific change to guidelines or clinical practice was announced with the study.

Further research that follows women over time could help determine how symptoms change for individuals and whether the observed differences persist after accounting for other factors. For now, the review supports awareness of anxiety during perimenopause while leaving its causes, individual course and best response unresolved.

Key Questions

What did the review find about anxiety during perimenopause?

Women in perimenopause had 59% higher odds of reporting anxiety symptoms than premenopausal women in the pooled analysis. The authors reported substantial variation among studies.

Did postmenopausal women also have higher odds?

Yes. Their odds of reported anxiety symptoms were 63% higher than those of premenopausal women in the pooled comparison. In a direct comparison, postmenopausal women had 21% lower odds than perimenopausal women.

Does the study prove menopause causes anxiety?

No. The evidence was observational and shows an association between menopausal stage and reported anxiety, not that menopause causes anxiety.

How many women and studies were included?

The review covered 21 studies and 24,523 women. Fifteen studies contributed data to the meta-analysis.

What remains uncertain?

The analysis does not establish how anxiety changes within individual women over time, what causes the group differences, or the absolute proportion of women affected at each stage. Study results also varied substantially.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

‘Explosive’ diarrhea illness reported across US. See map of affected states

An outbreak of severe diarrhea has been reported across several US states, prompting health alerts. See affected areas on the map.

Drug-Eluting Intraocular Lens Passes Test In Patients With Cataracts And Glaucoma

A 104-patient trial found a bimatoprost-releasing cataract lens noninferior to timolol drops for lowering eye pressure at 12 months.

Is the Bone Conduction Personal Sound Amplifier Open-Ear Worth It? Honest Take + Alternatives

A detailed review of the Bone Conduction Personal Sound Amplifier, exploring if its open-ear design, long battery life, and water resistance make it a worthwhile choice.

New AI Framework Improves Early Screening For Parkinson’s Disease

An RPI-led study reports that Quest2Dx can identify Parkinson’s-related patterns in long health questionnaires, but it is a screening tool, not a diagnosis.